Prognostic factors in muscle-infiltrating bladder cancer (MIBC) treated with an organ-sparing treatment with concurrent gemcitabine (GEM) and radiotherapy (XRT): Results of a patient-based cumulative analysis of seven phase I-II trials

Orazio Caffo; Catherine Thompson; Maria De Santis; Borut Kragelj; Daniel A. Hamstra; David Azria; Giovanni Pappagallo; Giovanni Fellin; Ananya Choudhury

doi:10.1200/jco.2015.33.15_suppl.e15529

Retour

Prognostic factors in muscle-infiltrating bladder cancer (MIBC) treated with an organ-sparing treatment with concurrent gemcitabine (GEM) and radiotherapy (XRT): Results of a patient-based cumulative analysis of seven phase I-II trials

Article de revue

Avec comité de lecture

Prognostic factors in muscle-infiltrating bladder cancer (MIBC) treated with an organ-sparing treatment with concurrent gemcitabine (GEM) and radiotherapy (XRT): Results of a patient-based cumulative analysis of seven phase I-II trials

Orazio Caffo, Catherine Thompson, Maria De Santis, Borut Kragelj, Daniel A. Hamstra, David Azria, Giovanni Pappagallo, Giovanni Fellin et Ananya Choudhury

Journal of clinical oncology, Vol.33(15_suppl), pp.e15529-e15529

20/05/2015

DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.e15529

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Titre: Prognostic factors in muscle-infiltrating bladder cancer (MIBC) treated with an organ-sparing treatment with concurrent gemcitabine (GEM) and radiotherapy (XRT): Results of a patient-based cumulative analysis of seven phase I-II trials
Créateurs - sans rôle: Orazio Caffo - Ospedale Santa Chiara
Catherine Thompson - The Christie NHS Foundation Trust
Maria De Santis - LBI-ACR Vienna, Kaiser Franz Josef Hospital, Center for Oncology and Hematology, Vienna, Austria
Borut Kragelj - Institute of Oncology Ljubljana
Daniel A. Hamstra - Michigan Medicine
David Azria - Institut Régional du Cancer Montpellier, Montpellier, France
Giovanni Pappagallo - Azienda ULSS 13, Mirano, Italy
Giovanni Fellin - Ospedale Santa Chiara, Trento, Italy
Ananya Choudhury - The Christie NHS Foundation Trust
Détails de publication: Journal of clinical oncology, Vol.33(15_suppl), pp.e15529-e15529
Identifiants: 99141276709311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article